RaQualia Pharma Inc
TSE:4579
Income Statement
Earnings Waterfall
RaQualia Pharma Inc
Revenue
|
1.9B
JPY
|
Cost of Revenue
|
-245.1m
JPY
|
Gross Profit
|
1.7B
JPY
|
Operating Expenses
|
-2B
JPY
|
Operating Income
|
-337.4m
JPY
|
Other Expenses
|
13.7m
JPY
|
Net Income
|
-323.7m
JPY
|
Income Statement
RaQualia Pharma Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
228
N/A
|
220
-3%
|
241
+10%
|
229
-5%
|
154
-33%
|
143
-7%
|
103
-28%
|
94
-9%
|
146
+55%
|
738
+407%
|
718
-3%
|
726
+1%
|
705
-3%
|
518
-26%
|
552
+6%
|
673
+22%
|
1 419
+111%
|
1 398
-2%
|
1 402
+0%
|
1 346
-4%
|
745
-45%
|
696
-7%
|
844
+21%
|
920
+9%
|
1 703
+85%
|
1 479
-13%
|
1 530
+3%
|
1 568
+3%
|
1 107
-29%
|
1 639
+48%
|
2 055
+25%
|
2 157
+5%
|
2 776
+29%
|
2 460
-11%
|
2 903
+18%
|
3 057
+5%
|
2 918
-5%
|
2 949
+1%
|
2 485
-16%
|
2 509
+1%
|
1 901
-24%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(0)
|
(3)
|
(3)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
(118)
|
(118)
|
(118)
|
(118)
|
(114)
|
(123)
|
(131)
|
(150)
|
(55)
|
(61)
|
(75)
|
(89)
|
(159)
|
(186)
|
(199)
|
(263)
|
(200)
|
(190)
|
(195)
|
(138)
|
(154)
|
(255)
|
(310)
|
(321)
|
(332)
|
(250)
|
(220)
|
(232)
|
(238)
|
(249)
|
(253)
|
(245)
|
|
Gross Profit |
197
N/A
|
217
+10%
|
239
+10%
|
227
-5%
|
151
-33%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
487
N/A
|
500
+3%
|
521
+4%
|
588
+13%
|
405
-31%
|
429
+6%
|
542
+26%
|
1 270
+134%
|
1 343
+6%
|
1 341
0%
|
1 271
-5%
|
655
-48%
|
537
-18%
|
658
+23%
|
721
+10%
|
1 440
+100%
|
1 279
-11%
|
1 340
+5%
|
1 374
+3%
|
969
-29%
|
1 486
+53%
|
1 800
+21%
|
1 847
+3%
|
2 456
+33%
|
2 128
-13%
|
2 652
+25%
|
2 838
+7%
|
2 686
-5%
|
2 711
+1%
|
2 236
-18%
|
2 256
+1%
|
1 656
-27%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(2 366)
|
(2 424)
|
(2 236)
|
(2 218)
|
(2 335)
|
(2 264)
|
(2 242)
|
(2 295)
|
(2 010)
|
(1 904)
|
(1 689)
|
(1 430)
|
(1 347)
|
(1 344)
|
(1 369)
|
(1 381)
|
(1 420)
|
(1 674)
|
(1 697)
|
(1 703)
|
(1 730)
|
(1 476)
|
(1 477)
|
(1 494)
|
(1 456)
|
(1 464)
|
(1 457)
|
(1 456)
|
(1 455)
|
(1 549)
|
(1 568)
|
(1 625)
|
(1 748)
|
(1 689)
|
(1 708)
|
(1 736)
|
(1 820)
|
(1 834)
|
(1 944)
|
(1 999)
|
(1 994)
|
|
Selling, General & Administrative |
(848)
|
(863)
|
(846)
|
(825)
|
(819)
|
(787)
|
(777)
|
(757)
|
(699)
|
(666)
|
(593)
|
(566)
|
(543)
|
(569)
|
(586)
|
(592)
|
(563)
|
(636)
|
(639)
|
(628)
|
(648)
|
(579)
|
(576)
|
(594)
|
(587)
|
(585)
|
(572)
|
(556)
|
(518)
|
(585)
|
(590)
|
(587)
|
(615)
|
(553)
|
(549)
|
(549)
|
(565)
|
(581)
|
(621)
|
(656)
|
(621)
|
|
Research & Development |
(1 518)
|
(1 479)
|
(1 391)
|
(1 393)
|
(1 516)
|
(1 477)
|
(1 465)
|
(1 538)
|
(1 302)
|
(1 238)
|
(1 096)
|
(865)
|
(796)
|
(775)
|
(783)
|
(789)
|
(772)
|
(1 038)
|
(1 058)
|
(1 075)
|
(958)
|
(897)
|
(902)
|
(901)
|
(733)
|
(878)
|
(885)
|
(900)
|
(813)
|
(965)
|
(978)
|
(1 038)
|
(991)
|
(1 135)
|
(1 159)
|
(1 187)
|
(1 107)
|
(1 253)
|
(1 324)
|
(1 343)
|
(1 373)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(9)
|
0
|
0
|
0
|
(8)
|
0
|
0
|
0
|
(84)
|
0
|
0
|
0
|
(125)
|
0
|
0
|
0
|
(136)
|
0
|
0
|
0
|
(124)
|
0
|
0
|
0
|
(142)
|
0
|
0
|
0
|
(148)
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
(82)
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
|
Operating Income |
(2 138)
N/A
|
(2 207)
-3%
|
(1 998)
+9%
|
(1 992)
+0%
|
(2 184)
-10%
|
(2 121)
+3%
|
(2 139)
-1%
|
(2 201)
-3%
|
(1 865)
+15%
|
(1 284)
+31%
|
(1 089)
+15%
|
(822)
+25%
|
(760)
+8%
|
(939)
-24%
|
(940)
0%
|
(839)
+11%
|
(150)
+82%
|
(331)
-120%
|
(356)
-8%
|
(431)
-21%
|
(1 075)
-149%
|
(939)
+13%
|
(819)
+13%
|
(774)
+6%
|
(16)
+98%
|
(185)
-1 061%
|
(117)
+37%
|
(83)
+29%
|
(486)
-488%
|
(64)
+87%
|
232
N/A
|
222
-5%
|
708
+219%
|
439
-38%
|
944
+115%
|
1 102
+17%
|
866
-21%
|
877
+1%
|
291
-67%
|
257
-12%
|
(337)
N/A
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
802
|
2 313
|
2 281
|
2 407
|
1 605
|
142
|
218
|
132
|
157
|
72
|
(33)
|
(72)
|
8
|
39
|
125
|
151
|
57
|
4
|
14
|
22
|
(5)
|
71
|
25
|
5
|
50
|
38
|
47
|
18
|
(43)
|
75
|
80
|
123
|
184
|
133
|
252
|
239
|
66
|
3
|
(36)
|
(27)
|
54
|
|
Non-Reccuring Items |
(83)
|
0
|
(70)
|
(116)
|
(59)
|
(57)
|
(103)
|
(90)
|
(134)
|
(127)
|
(63)
|
(33)
|
8
|
(1)
|
(5)
|
(2)
|
1
|
(0)
|
(2)
|
(2)
|
(1)
|
2
|
5
|
7
|
4
|
8
|
3
|
0
|
(2)
|
(10)
|
(17)
|
(25)
|
(20)
|
(52)
|
(74)
|
(27)
|
(65)
|
(48)
|
(46)
|
(93)
|
(22)
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
317
|
339
|
53
|
49
|
6
|
5
|
6
|
9
|
(7)
|
(6)
|
15
|
21
|
21
|
20
|
45
|
45
|
32
|
33
|
(10)
|
(11)
|
3
|
(7)
|
(8)
|
(10)
|
(11)
|
(0)
|
(1)
|
1
|
2
|
5
|
9
|
8
|
9
|
4
|
(2)
|
(4)
|
(16)
|
(6)
|
2
|
4
|
11
|
|
Pre-Tax Income |
(1 102)
N/A
|
445
N/A
|
266
-40%
|
348
+31%
|
(632)
N/A
|
(2 031)
-221%
|
(2 018)
+1%
|
(2 151)
-7%
|
(1 848)
+14%
|
(1 346)
+27%
|
(1 169)
+13%
|
(906)
+23%
|
(723)
+20%
|
(880)
-22%
|
(774)
+12%
|
(644)
+17%
|
(60)
+91%
|
(295)
-392%
|
(354)
-20%
|
(422)
-19%
|
(1 078)
-155%
|
(874)
+19%
|
(797)
+9%
|
(772)
+3%
|
27
N/A
|
(140)
N/A
|
(66)
+53%
|
(63)
+5%
|
(528)
-742%
|
6
N/A
|
304
+4 921%
|
328
+8%
|
881
+168%
|
524
-41%
|
1 121
+114%
|
1 310
+17%
|
851
-35%
|
826
-3%
|
211
-74%
|
141
-33%
|
(294)
N/A
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(6)
|
(11)
|
(9)
|
(9)
|
(7)
|
(4)
|
(5)
|
(5)
|
(6)
|
(7)
|
(5)
|
(4)
|
(5)
|
(2)
|
1
|
2
|
2
|
(10)
|
(14)
|
(17)
|
(26)
|
(22)
|
(21)
|
(20)
|
(22)
|
(80)
|
(78)
|
(99)
|
(79)
|
(96)
|
(149)
|
(67)
|
(125)
|
(77)
|
(198)
|
(256)
|
(128)
|
(130)
|
68
|
(2)
|
(30)
|
|
Income from Continuing Operations |
(1 108)
|
433
|
257
|
339
|
(639)
|
(2 034)
|
(2 023)
|
(2 156)
|
(1 854)
|
(1 353)
|
(1 174)
|
(910)
|
(728)
|
(882)
|
(773)
|
(643)
|
(58)
|
(304)
|
(368)
|
(439)
|
(1 105)
|
(896)
|
(818)
|
(792)
|
5
|
(220)
|
(144)
|
(161)
|
(607)
|
(90)
|
155
|
261
|
756
|
446
|
922
|
1 054
|
723
|
696
|
279
|
139
|
(324)
|
|
Net Income (Common) |
(1 108)
N/A
|
433
N/A
|
257
-41%
|
339
+32%
|
(639)
N/A
|
(2 034)
-218%
|
(2 023)
+1%
|
(2 156)
-7%
|
(1 854)
+14%
|
(1 353)
+27%
|
(1 174)
+13%
|
(910)
+22%
|
(728)
+20%
|
(882)
-21%
|
(773)
+12%
|
(643)
+17%
|
(58)
+91%
|
(304)
-423%
|
(368)
-21%
|
(439)
-19%
|
(1 105)
-152%
|
(896)
+19%
|
(818)
+9%
|
(792)
+3%
|
5
N/A
|
(220)
N/A
|
(144)
+34%
|
(161)
-12%
|
(607)
-276%
|
(90)
+85%
|
155
N/A
|
261
+68%
|
756
+190%
|
446
-41%
|
922
+107%
|
1 054
+14%
|
723
-31%
|
696
-4%
|
279
-60%
|
139
-50%
|
(324)
N/A
|
|
EPS (Diluted) |
-81.48
N/A
|
31.62
N/A
|
18.9
-40%
|
24.4
+29%
|
-45.63
N/A
|
-136.53
-199%
|
-135.77
+1%
|
-136.44
0%
|
-116.45
+15%
|
-71.95
+38%
|
-62.43
+13%
|
-48.39
+22%
|
-38.8
+20%
|
-46.19
-19%
|
-40.28
+13%
|
-33.3
+17%
|
-2.99
+91%
|
-14.98
-401%
|
-18.01
-20%
|
-21.51
-19%
|
-54.23
-152%
|
-43.95
+19%
|
-39.99
+9%
|
-38.29
+4%
|
0.26
N/A
|
-10.49
N/A
|
-6.88
+34%
|
-7.7
-12%
|
-28.97
-276%
|
-4.31
+85%
|
7.41
N/A
|
12.45
+68%
|
36.04
+189%
|
21.29
-41%
|
43.96
+106%
|
50.23
+14%
|
34.47
-31%
|
32.25
-6%
|
12.91
-60%
|
6.41
-50%
|
-14.98
N/A
|